Valdés-Sánchez, L.; Borrego-González, S.; Montero-Sánchez, A.; Massalini, S.; de la Cerda, B.; DÃaz-Cuenca, A.; DÃaz-Corrales, F.J.
Mesoporous Silica-Based Nanoparticles as Non-Viral Gene Delivery Platform for Treating Retinitis Pigmentosa. J. Clin. Med. 2022, 11, 2170.
https://doi.org/10.3390/jcm11082170
AMA Style
Valdés-Sánchez L, Borrego-González S, Montero-Sánchez A, Massalini S, de la Cerda B, DÃaz-Cuenca A, DÃaz-Corrales FJ.
Mesoporous Silica-Based Nanoparticles as Non-Viral Gene Delivery Platform for Treating Retinitis Pigmentosa. Journal of Clinical Medicine. 2022; 11(8):2170.
https://doi.org/10.3390/jcm11082170
Chicago/Turabian Style
Valdés-Sánchez, Lourdes, Sara Borrego-González, Adoración Montero-Sánchez, Simone Massalini, Berta de la Cerda, Aránzazu DÃaz-Cuenca, and Francisco J. DÃaz-Corrales.
2022. "Mesoporous Silica-Based Nanoparticles as Non-Viral Gene Delivery Platform for Treating Retinitis Pigmentosa" Journal of Clinical Medicine 11, no. 8: 2170.
https://doi.org/10.3390/jcm11082170
APA Style
Valdés-Sánchez, L., Borrego-González, S., Montero-Sánchez, A., Massalini, S., de la Cerda, B., DÃaz-Cuenca, A., & DÃaz-Corrales, F. J.
(2022). Mesoporous Silica-Based Nanoparticles as Non-Viral Gene Delivery Platform for Treating Retinitis Pigmentosa. Journal of Clinical Medicine, 11(8), 2170.
https://doi.org/10.3390/jcm11082170